The first total synthesis of the novel triquinane natural products pleurotellol and pleurotellic acid by Mehta, Goverdhan & Sai Krishna Murthy, A.
The first total synthesis of the novel triquinane natural products
pleurotellol and pleurotellic acid
Goverdhan Mehta* and A. Sai Krishna Murthy
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Abstract—The first total synthesis of the triquinane based sesquiterpenoid antibiotics (±)-pleurotellol and (±)-pleurotellic acid
isolated from the fermentation broth of Pleurotellus hypnophilus have been accomplished. The triquinane based bis-enone system
obtained via photo-thermal metathesis in a caged pentacyclic dione has been elaborated to the natural products through carefully
crafted functional group transformations. 
Natural products embodying either a linearly-fused or
angularly-fused triquinane framework continue to sur-
face in the literature at regular intervals from diverse
sources like marine organisms, microbial fermentation
broths and terrestrial plants.1 Among these, sesquiter-
penoids based on the linearly-fused tricyclo[6.3.0.02,6]-
undecane skeleton 1 have aroused a great deal of
interest on account of their skeletal and functional
diversity that poses a considerable synthetic challenge.2
Five different skeletal types, differing in the disposition
of the methyl groups and functionalization pattern on
the basic framework 1, have been encountered so far
among naturally occurring sesquiterpenoids. These are
represented by coriolin 2 (hirsutane type), cucumin E 3
(isohirsutane type), ceratopicanol 4 (ceratopicane type),
capnellene 5 (capnellane type) and pleurotellol 6
(pleurotellane type)2 and they all share a common
biogenetic origin emanating from the farnesyl
pyrophosphate derived humulenyl cation.
In a collaborative endeavor, the research groups of
Steglich and Anke3 reported the isolation and structure
determination of the sesquiterpenoid antibiotics
pleurotellol 6 and pleurotellic acid 7 from the mycelial
cultures of Pleurotellus hypnophilus (Berc.) Sacc. (Agar-
icales). Structures of 6 and 7, representing a rearranged
hirsutane skeleton, were deduced on the basis of NMR
decoupling studies and biosynthetic considerations.3c
While syntheses of several members of the skeletal types
represented by 2–5 have been reported in recent
years,2,4 pleurotellol 6 and the related pleurotellic acid 7
have not yielded to synthesis, despite being known for
nearly two decades. This in part could be attributed to
the high level of functionalization present in the two
peripheral five membered rings of the triquinane frame-
work present in 6 and 7. As part of our continuing
interest5 in the synthesis of linearly fused triquinane
natural products, we have now accomplished the first
syntheses of pleurotellol 6 and pleurotellic acid 7 in
racemic form, which also reconfirm their structural
assignments.3c
For the synthesis of natural products 6 and 7, we opted
for the photo-thermal metathesis based approach delin-
eated by us sometime ago5a,b as it rapidly delivers a
linear triquinane system in which the peripheral five-
membered rings are adequately functionalized for fur-
ther manipulation. Pentacyclic dione 8,5b readily
available from cyclopentadiene and 2,5-dimethyl-p-ben-
zoquinone in two steps, served as the starting point and
was elaborated to the cis, syn, cis-fused triquinane
bis-enone 9 through flash vacuum pyrolysis as
described earlier by us.5b,f Thermally induced equilibra-
tion in 9 led to the thermodynamically more stable cis,
anti, cis-fused triquinane bis-enone 10 (Scheme 1).5f* Corresponding author. E-mail: gm@orgchem.iisc.ernet.in
Scheme 1. Reagents and conditions : (a) FVP, 590–610°C, 10−2 torr, 85–90%; (b) benzyl benzoate, 320°C, 20 min, 85% after three
equilibration cycles; (c) 10% PdC, H2, 25 psi, EtOAc, 5 h, quant.; (d) ethylene glycol, CSA, benzene, reflux, 12 h, 90%; (e)
PPh3CH3Br, tBuO
−K+, THF, reflux, 8 h, 85%; (f) mCPBA, NaHCO3, DCM, 0°C–rt, 30 min, 90%; (g) TMSOTf, DMAP,
pyridine, 0°C–rt, 3 h, 80–85% overall (57% of 15 and 28% of 16).
Catalytic hydrogenation of 10 to 11 and further
regioselective mono-ketalization led to 12, in which the
two carbonyl groups were differentiated and the car-
bonyl group next to the quaternary center had been
protected (Scheme 1).6 Wittig olefination in 12 was
smooth and delivered the methylenecyclopentane
derivative 136 quite uneventfully. The key allylic alco-
hol functionality of the natural product was sought to
be generated from 13 through an epoxidation and ring
opening protocol. Epoxidation of the terminal olefinic
bond in 13 with m-chloroperbenzoic acid furnished a
single spiro-epoxide 14 in good yield (Scheme 1).
TMSOTf mediated opening of the epoxide ring in 14
under conditions that favor the formation of allylic
alcohols led to a 2:1 mixture of 15 and 16 in which the
desired alcohol 15 was the major product (Scheme 1).
The two tricyclic alcohols 15 and 16 were separated
through silica gel column chromatography and were
fully characterized.6 Concurrent formation of 16
through double bond isomerization was indicative of
the sterically encumbered nature of the tetrasubstituted
cyclopentene moiety present in 15 and natural products
6 and 7. Indeed, we observed that epoxide 14 when
exposed to a variety of Lewis or protic acid catalysts
exhibited marked propensity towards the formation of
the ring-opened product with double-bond migration to
the less substituted position as in 16.
With the functionalization in one of the five membered
rings secured, attention was turned towards building-up
the more complex epoxy-cyclopentadienenone pattern
in the other peripheral five membered ring. Protection
of the primary hydroxyl group in 15 as the
methoxymethyl derivative also resulted in ketal depro-
tection and led to the cyclopentanone derivative 17
(Scheme 2).6 Wittig olefination furnished the exo-meth-
ylene compound 18. Allylic oxidation in 18 with excess
selenium dioxide directly delivered the enone 196
through the intermediacy of the corresponding allylic
alcohol whose formation was also observed when the
reaction was intercepted before full conversion to 19
(Scheme 2). The dienone moiety was generated follow-
ing the Saegusa procedure7 involving formation of
TMS–enol ether and palladium mediated oxidative
dehydrosilylation to furnish 20 (Scheme 2). At this
stage, the relatively straightforward looking deprotec-
tion of the MOM protective group in 20 proved to be
quite cumbersome due to the migration of the tetra-
substituted double bond (vide supra) to the less substi-
tuted position (cf. 16) and only after many trials could
conditions be devised to deliver 21 satisfactorily. Lastly,
exposure of tricyclic dienone 21 to hydrogen peroxide
in a basic medium delivered pleurotellol 6, which was
found to be spectroscopically (IR, 1H and 13C NMR)
identical with the natural product.6 Since, pleurotellol 6
has already been converted to pleurotellic acid 7,3c our
synthesis of 6 also constitutes a formal synthesis of 7.
In summary, we have achieved a total synthesis of the
novel triquinane based sequiterpenoid antibiotics (±)-
pleurotellol 6 and (±)-pleurotellic acid 7, following an
adaptation of the versatile photo-thermal metathesis
based approach to linearly fused tricyclopentanoids.
Installation of the sensitive functionalization pattern in
Scheme 2. Reagents and conditions : (a) MOMCl, Et3N, DCM, 0°C–rt, 4 h, 75%; (b) PPh3CH3Br, tBuO−K+, THF, rt, 6–8h, 80%;
(c) SeO2, TBHP, DCM, rt, 6–8 h, 85%; (d) (i) LDA, THF, DMPU, TMSCl, −10°C, 6 h; (ii) Pd(OAc)2, CH3CN, rt, 5 h, 50%; (e)
isopropyl alcohol, conc. HCl, 55°C, 10 h, 80%; (f) 30% H2O2, K2CO3, H2O, DCM, 0°C–rt, 12h, 50% conversion; (g) Ref. 3c.
the two peripheral five-membered rings of the
triquinane system through short and simple reaction
sequences is the other notable feature of our synthesis.
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